These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 6804139)

  • 1. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man.
    Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B
    Biomedicine; 1981 Oct; 35(5):142-4. PubMed ID: 6797487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Melanocyte--stimulating hormone and adrenocorticotropin concentrations in response to thyrotropin-releasing hormone and comparison with adrenocorticotropin concentration after domperidone administration in healthy horses and horses with pituitary pars intermedia dysfunction.
    Beech J; McFarlane D; Lindborg S; Sojka JE; Boston RC
    J Am Vet Med Assoc; 2011 May; 238(10):1305-15. PubMed ID: 21568777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic modulation of growth hormone, prolactin and thyroid stimulating hormone responses to thyrotropin-releasing hormone in normal aging.
    Giusti M; Giovale M; Sessarego P; Carraro A; Pompei A; Giordano G
    Recenti Prog Med; 1995 Sep; 86(9):341-4. PubMed ID: 7569294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thyrotropin, prolactin, and growth-hormone responses to thyrotropin-releasing hormone in healthy subjects over eighty years (author's transl)].
    Shigemasa C; Okamura Y; Yoshida A; Onoyama S; Watanabe K; Mashiba H; Abe K
    Nihon Ronen Igakkai Zasshi; 1981 Nov; 18(6):403-9. PubMed ID: 6803041
    [No Abstract]   [Full Text] [Related]  

  • 6. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypothalamic and thyroidal regulation of growth hormone in tilapia.
    Melamed P; Eliahu N; Levavi-Sivan B; Ofir M; Farchi-Pisanty O; Rentier-Delrue F; Smal J; Yaron Z; Naor Z
    Gen Comp Endocrinol; 1995 Jan; 97(1):13-30. PubMed ID: 7713377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of domperidone on serum TSH and growth hormone in thyroid patients.
    Földes J; Bános C; Lakatos P; Takó J
    Acta Med Hung; 1985; 42(3-4):133-43. PubMed ID: 4094840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of domperidone on prolactin (PRL)and thyrotrophin (TSH) secretion.
    Kaufman JM; Elewaut A; Vermeulen A
    Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):293-303. PubMed ID: 6802092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased growth hormone responses to growth hormone releasing hormone and thyrotropin releasing hormone in patients with metastatic testicular cancer.
    Pietschmann P; Kuzmits R; Schernthaner G
    Horm Metab Res; 1990 Feb; 22(2):109-13. PubMed ID: 2108920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between human pancreatic growth hormone releasing factor (hpGRF) and thyrotropin releasing hormone (TRH) on growth hormone secretion in domestic fowl.
    Harvey S; Scanes CG
    Horm Metab Res; 1985 Feb; 17(2):113-4. PubMed ID: 3921448
    [No Abstract]   [Full Text] [Related]  

  • 12. Immediate effects of intermittent administration of domperidone upon prolactin release in normal women.
    Ulloa-Aguirre A; del Real O; Méndez JP; Garza-Flores J; Larrea F; Martínez-Campos A
    Rev Invest Clin; 1985; 37(4):341-5. PubMed ID: 3938045
    [No Abstract]   [Full Text] [Related]  

  • 13. Dissociated response of thyrotropin and prolactin to dopamine receptor blockade with domperidone in hypothyroid subjects.
    Marcondes JA; Santomauro AT; Minanni SL; Wajchenberg BL
    Horm Metab Res; 1991 Dec; 23(12):605-8. PubMed ID: 1778595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone response to thyrotropin-releasing hormone in liver cirrhosis: unique alteration in anterior pituitary responsiveness to hypothalamic hormones.
    Salerno F; Cocchi D; Lampertico M; Manneschi M; Monza G; Müller EE
    Horm Metab Res; 1982 Sep; 14(9):482-6. PubMed ID: 6128295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
    Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of domperidone on gastric movement and blood flow in dog (author's transl)].
    Fujii K; Takasugi S
    Nihon Heikatsukin Gakkai Zasshi; 1980 Mar; 16(1):37-46. PubMed ID: 7277931
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of domperidone on GH secretion in normal controls and in cancer patients (author's transl)].
    Kamijo K; Kato J; Saito A; Suzuki M; Taniuchi A
    Horumon To Rinsho; 1981 Nov; 29(11):1395-7. PubMed ID: 6804139
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence of abnormal dopaminergic control of prolactin in patients with hypothalamic and pituitary tumors.
    Cabranes JA; Almoguera I; del Olmo J; Prensa A; Pablos I; Charro AL
    J Med; 1986; 17(1):25-39. PubMed ID: 3035040
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.